The Role of Inflammasomes in Atherosclerosis and Stroke Pathogenesis.

Current pharmaceutical design 2020

filter terms:

Inflammation is a devastating outcome of cerebrovascular diseases (CVD), namely stroke and atherosclerosis. Numerous studies over the decade have shown that inflammasomes play a role in mediating inflammatory reactions post cellular injury occurring after a stroke or a rupture of an atherosclerotic plaque. In view of this, targeting these inflammatory pathways using different pharmacological therapies may improve outcomes in patients with CVD. Here, we review the mechanisms by which inflammasomes drive the pathogenesis of stroke and atherosclerosis. Also, discussed here are the possible treatment strategies available for inhibiting inflammasomes or their up-stream/down-stream mediators. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Citation

Deepaneeta Sarmah, Aishika Datta, Swapnil Raut, Ankan Sarkar, Birva Shah, Mariya Bohra, Upasna Singh, Priya Jagtap, Falguni Baidya, Kiran Kalia, Xin Wang, Kunjan R Dave, Dileep R Yavagal, Pallab Bhattacharya. The Role of Inflammasomes in Atherosclerosis and Stroke Pathogenesis. Current pharmaceutical design. 2020;26(34):4234-4245